Cite
HARVARD Citation
Schmidinger, M. et al. (2022). Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study. Acta oncologica. pp. 52-57. [Online].